Company page

Rapport Therapeutics, Inc.

Rapport Therapeutics, Inc. (Ticker: RAPP) is a public company operating in the American market, with a market capitalization of approximately $2.04 billion. The company focuses on developing innovative therapeutic solutions. Investors can find more information about its operations and performance on its dedicated public company page.

RAPP:NASDAQUpdated September 11, 2026
Rapport Therapeutics, Inc. logo
Ticker
RAPP:NASDAQ
Asset type
Stock
Market cap
$2.09B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD